Stanford University
Showing 11-20 of 240 Results
-
Andrea J Ibarra
Instructor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Ibarra is a board-certified anesthesiologist with a focused research interest in preeclampsia and brain health. She completed her anesthesiology training at the University of Pittsburgh in 2019. Committed to bridging clinical excellence with rigorous scientific inquiry, Dr. Ibarra earned a master's degree in clinical research at Pitt. In 2023, her research promise was recognized with the prestigious SOAP-FAER Mentored Research Training Grant, which investigated the long-term neurological implications of preeclampsia. Her research portfolio centers on the intersection of anesthesia, women's health outcomes, and cognitive function, contributing to the growing body of evidence in perioperative neuroscience.
Outside of her clinical and academic pursuits, Dr. Ibarra is passionate about cooking and travel, drawing inspiration from diverse cultures around the world. -
Stephanie Ibe
Research Program Coordinator NOURISH - Casual, Medicine - Primary Care and Population Health
Current Role at StanfordResearch Program Coordinator - NOURISH
-
Huda Ibeid
Graduate, Stanford Center for Professional Development
BioHuda Ibeid is a Senior Data Center Performance Engineer at NVIDIA. Previously, she was an HPC Performance Architect at Intel, where she worked on performance bring-up and optimization of large-scale applications on the Aurora exascale supercomputer. She holds a PhD in Computer Science from King Abdullah University of Science and Technology (KAUST). Her research interests include high-performance computing, performance modeling, GPU computing, and scalable numerical algorithms. She is a recipient of the Rising Stars in EECS award and the Google Women Techmakers Scholarship.
-
David Iberri
Clinical Associate Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
